Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T19:41:00.291Z.
Calculation as of: 2026-10-06T19:41:00.291Z.
Quote observation: 2026-10-06T19:40:18.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: bae8dd55c1776b4784265b7d6b815fecf0da21712464e51122872d0292d60ac3
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$3.44B
Free Cash Flow Yield
N/A
TTM Avg
9.07%
3Y Avg
9.10%
5Y Avg
9.10%
Market Cap
$3.51B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.41B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.53B
Free Cash Flow Yield
1.10%
TTM Avg
0.68%
3Y Avg
0.59%
5Y Avg
0.59%
Market Cap
$3.55B
Free Cash Flow Yield
4.66%
TTM Avg
3.79%
3Y Avg
2.70%
5Y Avg
2.46%
Market Cap
$3.38B
Free Cash Flow Yield
5.16%
TTM Avg
3.81%
3Y Avg
3.52%
5Y Avg
3.52%
Market Cap
$3.56B
Free Cash Flow Yield
N/A
TTM Avg
6.75%
3Y Avg
6.75%
5Y Avg
6.75%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Celcuity Inc. (CELC) | $3.47B | N/A | N/A | N/A | N/A |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.44B | N/A | 9.07% | 9.10% | 9.10% |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.51B | N/A | N/A | N/A | N/A |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.41B | N/A | N/A | N/A | N/A |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.53B | 1.10% | 0.68% | 0.59% | 0.59% |
| Veracyte, Inc. (VCYT)vs › | $3.55B | 4.66% | 3.79% | 2.70% | 2.46% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 5.16% | 3.81% | 3.52% | 3.52% |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.56B | N/A | 6.75% | 6.75% | 6.75% |
| CareDx, Inc (CDNA)vs › | $3.36B | 2.53% | 3.72% | 2.68% | 2.68% |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.33B | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
